Noho Health Inc.

Noho Health Inc. is a health-focused company that provides personalized nutritional products, including tailored vitamin and supplement packs designed to meet individual dietary needs and lifestyle goals. Founded in 2016 in New York, US, Noho Health Inc. specializes in personalized nutrition solutions.

The company has undergone significant growth, culminating in a Series C funding round where it raised USD 40. 67 mn, bringing the total amount raised to USD 40. 67 mn and a current valuation of USD 215. 198 mn.

The company has secured a total of 6 deals, with the most recent occurring on August 31, 2020. The founders, Akash Shah and Bridget Love, have a history of innovation in the health and wellness space. Noho Health Inc. specializes in personalized nutritional products and services designed to meet the individual health needs of its customers.

Central to its offerings are tailored vitamin and supplement packs, which are based on users' specific dietary requirements and lifestyle goals. These products address common health concerns such as energy levels, immunity, and overall wellness, enhancing consumers' quality of life. The company operates primarily in the United States and Europe, catering to health-conscious consumers seeking effective nutrition solutions. Customers can easily access these products through an online platform, which is convenient for diverse client bases, including fitness enthusiasts and busy professionals.

The company's revenue model is based on a subscription service that allows customers to receive personalized supplement packs regularly. This B2C approach fosters customer loyalty and ensures consistent revenue generation. Customers can choose from various pricing plans, including options for one-time purchases or recurring shipments tailored to their needs. The flagship products are designed to be accessible and effective, appealing to a broad market segment, emphasizing convenience and personalization as key components of the company's value proposition in the wellness industry.

In August 2020, Bayer AG agreed to acquire a 70% majority stake in Noho Health Inc. The recent funding will support the development of new products tailored to specific health concerns and expand into new markets, particularly targeting Europe and potential entry into Asia by 2023. The integration with Bayer AG may enhance resource access for product innovation and market penetration.